Skip to content
10-Q

Quarterly Report

Kite Pharma, Inc.

0001510580-16-000004

← back to feed
Filed
Nov 9, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Nov 8, 2016 49.88M sh
Capex Q3 2016 · Sep 30, 2016 $17.03M
Capex Q3 2016 · Sep 30, 2015 $18.71M
Cash And Equivalents Q3 2016 · Sep 30, 2016 $128.75M
Cash And Equivalents Q3 2016 · Dec 31, 2015 $392.84M
Cash And Equivalents Q3 2016 · Sep 30, 2015 $172.97M
Cash And Equivalents Q3 2016 · Dec 31, 2014 $209.3M
Stockholders Equity Q3 2016 · Sep 30, 2016 $494.35M
Stockholders Equity Q3 2016 · Dec 31, 2015 $615.76M
Current Liabilities Q3 2016 · Sep 30, 2016 $47.36M
Current Liabilities Q3 2016 · Dec 31, 2015 $36.17M
Total Liabilities Q3 2016 · Sep 30, 2016 $90.16M
Total Liabilities Q3 2016 · Dec 31, 2015 $92.2M
Current Assets Q3 2016 · Sep 30, 2016 $491.11M
Current Assets Q3 2016 · Dec 31, 2015 $631.09M
Total Assets Q3 2016 · Sep 30, 2016 $584.52M
Total Assets Q3 2016 · Dec 31, 2015 $707.96M
Sga Expense Q3 2016 · Sep 30, 2016 $25.03M
Sga Expense Q3 2016 · Sep 30, 2016 $65.05M
Sga Expense Q3 2016 · Sep 30, 2015 $11.14M
Sga Expense Q3 2016 · Sep 30, 2015 $30.08M
Rd Expense Q3 2016 · Sep 30, 2016 $57.26M
Rd Expense Q3 2016 · Sep 30, 2016 $139.03M
Rd Expense Q3 2016 · Sep 30, 2015 $21.73M
Rd Expense Q3 2016 · Sep 30, 2015 $47.58M
Net Income Q3 2016 · Sep 30, 2016 −$73.95M
Net Income Q3 2016 · Sep 30, 2016 −$182.14M
Net Income Q3 2016 · Sep 30, 2015 −$27.44M
Net Income Q3 2016 · Sep 30, 2015 −$63.42M
Operating Income Q3 2016 · Sep 30, 2016 −$74.95M
Operating Income Q3 2016 · Sep 30, 2016 −$186.82M
Operating Income Q3 2016 · Sep 30, 2015 −$27.78M
Operating Income Q3 2016 · Sep 30, 2015 −$65.29M
Revenue Q3 2016 · Sep 30, 2016 $7.34M
Revenue Q3 2016 · Sep 30, 2016 $17.26M
Revenue Q3 2016 · Sep 30, 2015 $5.09M
Revenue Q3 2016 · Sep 30, 2015 $12.37M